
doi: 10.1002/ccd.28746
pmid: 32034873
Key Points An early invasive strategy for NSTEMI resulted in lower MACE and recurrent ischemia compared with a delayed strategy. The significant risk of NSTEMI is affirmed, which warrants earlier and more directed invasive treatment. Future investigations need to confirm these findings in a randomized trial in high‐risk patients.
Treatment Outcome, Myocardial Infarction, Humans, Angina, Unstable, Acute Coronary Syndrome, Non-ST Elevated Myocardial Infarction
Treatment Outcome, Myocardial Infarction, Humans, Angina, Unstable, Acute Coronary Syndrome, Non-ST Elevated Myocardial Infarction
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 3 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
